Vancomycin in pharma franchise in Maharashtra

Vancomycin in PCD pharma franchise in Imphal

Vancomycin in top pharma company in Ludhiana

Vancomycin in pcd pharma supplier in Agra

Vancomycin in phama franchise company in India
Vancomycin in phama distributor in Nashik

Home/Products /vancomycin-500mg-injection

Vancoterm 500 Injection

Composition : Vancomycin (500mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 500mg

Price : ₹339/-

Vancoterm 500 Injection contains Vancomycin, a powerful antibiotic belonging to the glycopeptide class. It is formulated to combat severe bacterial infections, particularly those caused by Gram-positive pathogens. Vancomycin is renowned for its efficacy in treating methicillin-resistant Staphylococcus aureus (MRSA), severe skin and soft tissue infections, septicemia, endocarditis, bone and joint infections, and infections associated with implanted medical devices.

The mechanism of action involves inhibition of bacterial cell wall synthesis, which leads to bacterial cell death. This makes Vancoterm 500 an essential choice for combating multidrug-resistant bacteria. It is typically administered intravenously, ensuring rapid and direct delivery to the bloodstream for systemic infections.

This injection is frequently used in hospitalized patients and critical care settings, especially when other antibiotics are ineffective or unsuitable. Vancomycin is often reserved for cases requiring precise treatment of resistant infections, ensuring the most effective results in complex medical scenarios.

Read More

About the Product

Vancoterm 500 Injection contains Vancomycin, a powerful antibiotic belonging to the glycopeptide class. It is formulated to combat severe bacterial infections, particularly those caused by Gram-positive pathogens. Vancomycin is renowned for its efficacy in treating methicillin-resistant Staphylococcus aureus (MRSA), severe skin and soft tissue infections, septicemia, endocarditis, bone and joint infections, and infections associated with implanted medical devices.

The mechanism of action involves inhibition of bacterial cell wall synthesis, which leads to bacterial cell death. This makes Vancoterm 500 an essential choice for combating multidrug-resistant bacteria. It is typically administered intravenously, ensuring rapid and direct delivery to the bloodstream for systemic infections.

This injection is frequently used in hospitalized patients and critical care settings, especially when other antibiotics are ineffective or unsuitable. Vancomycin is often reserved for cases requiring precise treatment of resistant infections, ensuring the most effective results in complex medical scenarios.

Potential side effects include skin rash, itching, pain at the injection site, flushing, and, in rare cases, kidney dysfunction or hearing loss.

Effective for treating severe Gram-positive bacterial infections, including MRSA, septicemia, and severe skin, bone, and joint infections.

Vancoterm 500 Injection should only be used under medical supervision. Dosage adjustments are required for patients with renal impairment. Report any adverse reactions promptly to your healthcare provider.

Store below 25°C, away from light and moisture. Ensure it is kept out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation